Showing results (1901-1910 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|April 17, 2020
Metastatic Thymoma Harboring a Deleterious BRCA2 Mutation Derives Durable Clinical Benefit from OlaparibDaniel R Principe, Suneel D Kamath, Hidayatullah G Munshi, et al.The Oncologist|April 17, 2020
Development and Validation of a Prognostic Nomogram to Guide Decision-Making for High-Grade Digestive Neuroendocrine NeoplasmsZhenyu Lin, Haihong Wang, Yixuan Zhang, et al.The Oncologist|April 17, 2020
Immune-Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non-Small Cell Lung CancerHiroaki Akamatsu, Eriko Murakami, Jun Oyanagi, et al.The Oncologist|April 17, 2020
Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual DiseaseSahra Ali, Alexandre Moreau, Daniela Melchiorri, et al.The Oncologist|April 11, 2020
Prognostic Value of DNA Damage Response Genomic Alterations in Relapsed/Advanced Urothelial CancerMing Yin, Petros Grivas, Qi-En Wang, et al.The Oncologist|April 11, 2020
Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab EraChieh-Lung Cheng, Sheng-Chuan Huang, Jia-Hong Chen, et al.The Oncologist|April 12, 2020
Sustained Carbohydrate Antigen 19-9 Response to Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer Predicts Progression and SurvivalJ Bart Rose, Alicia M Edwards, Flavio G Rocha, et al.The Oncologist|February 13, 2001
Drug approval summaries: arsenic trioxide, tamoxifen citrate, anastrazole, paclitaxel, bexaroteneM H Cohen, S Hirschfeld, S Flamm Honig, et al.The Oncologist|February 13, 2001
Interferon in oncological practice: review of interferon biology, clinical applications, and toxicitiesE Jonasch, F G HaluskaThe Oncologist|February 13, 2001
The role of capecitabine, an oral, enzymatically activated fluoropyrimidine, in the treatment of metastatic breast cancerJ L BlumPageof 571